These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22624027)

  • 21. Comparison of age-specific patterns of sexual behaviour and anal HPV prevalence in homosexual men with patterns in women.
    Poynten IM; Machalek D; Templeton D; Jin F; Hillman R; Zablotzska I; Prestage G; Holt M; Grulich A
    Sex Transm Infect; 2016 May; 92(3):228-31. PubMed ID: 26306829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
    Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
    Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of genital human papillomavirus infection in a female adolescent population.
    Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
    Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
    Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
    J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway.
    Enerly E; Flingtorp R; Christiansen IK; Campbell S; Hansen M; Myklebust TÅ; Weiderpass E; Nygård M
    PLoS One; 2019; 14(10):e0223612. PubMed ID: 31600341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.
    Kojic EM; Conley L; Bush T; Cu-Uvin S; Unger ER; Henry K; Hammer J; Escota G; Darragh TM; Palefsky JM; Brooks JT; Patel P
    J Infect Dis; 2018 Apr; 217(10):1544-1552. PubMed ID: 29452366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical, anal and oral human papillomavirus (HPV) infection in young women: A case control study between women with perinatally HIV infection and women with non-perinatally HIV infection.
    Gilles C; Buljubasic M; Konopnicki D; Manigart Y; Barlow P; Rozenberg S
    Eur J Obstet Gynecol Reprod Biol; 2020 Jan; 244():114-119. PubMed ID: 31785467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination.
    Ong JJ; Walker S; Grulich A; Hoy J; Read TRH; Bradshaw C; Chen M; Garland SM; Cornall A; Hillman R; Templeton DJ; Hocking J; Eu B; Tee BK; Chow EPF; Fairley CK
    Sex Transm Dis; 2019 Apr; 46(4):229-233. PubMed ID: 30870323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anal and oral human papillomavirus infection in men who have sex with men: implications for risk-targeted vaccination.
    Donà MG; Rollo F; Latini A; Benevolo M; Pichi B; Pellini R; Giuliani E; Giglio A; Cristaudo A; Giuliani M
    Future Microbiol; 2020 Dec; 15():1713-1722. PubMed ID: 33404267
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpha, Beta, gamma human PapillomaViruses (HPV) detection with a different sets of primers in oropharyngeal swabs, anal and cervical samples.
    Sias C; Salichos L; Lapa D; Del Nonno F; Baiocchini A; Capobianchi MR; Garbuglia AR
    Virol J; 2019 Mar; 16(1):27. PubMed ID: 30832688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
    Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.
    Covert C; Ding L; Brown D; Franco EL; Bernstein DI; Kahn JA
    Hum Vaccin Immunother; 2019; 15(7-8):1962-1969. PubMed ID: 30633598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    McGregor S; Saulo D; Brotherton JML; Liu B; Phillips S; Skinner SR; Luey M; Oliver L; Stewart M; Tabrizi SN; Garland S; Kaldor JM
    Vaccine; 2018 Jul; 36(29):4311-4316. PubMed ID: 29880245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    Ucciferri C; Tamburro M; Falasca K; Sammarco ML; Ripabelli G; Vecchiet J
    J Med Virol; 2018 Feb; 90(2):358-366. PubMed ID: 28906006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.
    Combita AL; Reyes V; Puerto D; Murillo R; Sánchez R; Nuñez M; Hernandez-Suarez GA; Wiesner C
    Cancer Prev Res (Phila); 2022 Jan; 15(1):55-66. PubMed ID: 34610993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
    Kumakech E; Berggren V; Wabinga H; Lillsunde-Larsson G; Helenius G; Kaliff M; Karlsson M; Kirimunda S; Musubika C; Andersson S
    PLoS One; 2016; 11(8):e0160099. PubMed ID: 27482705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
    Ferré VM; Ekouevi DK; Gbeasor-Komlanvi FA; Collin G; Le Hingrat Q; Tchounga B; Salou M; Descamps D; Charpentier C; Dagnra AC
    Clin Microbiol Infect; 2019 Dec; 25(12):1560.e1-1560.e7. PubMed ID: 31051265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
    Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
    Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.
    Herrero R; Quint W; Hildesheim A; Gonzalez P; Struijk L; Katki HA; Porras C; Schiffman M; Rodriguez AC; Solomon D; Jimenez S; Schiller JT; Lowy DR; van Doorn LJ; Wacholder S; Kreimer AR;
    PLoS One; 2013; 8(7):e68329. PubMed ID: 23873171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.